XARELTO® is the #1 prescribed novel oral anticoagulant in the US*1


Incorrect dosing information was inadvertently displayed on this website recently. This has been corrected as of March 19, 2014. Please see the full Prescribing Information and Medication Guide, which were not affected. Click here for correct Dosing Information. Click here for Healthcare Professional Letter.

XARELTO® is available for multiple indications:

*Among Factor Xa inhibitors and direct thrombin inhibitors.


  1. Data on file. Janssen Pharmaceuticals, Inc. Based on IMS Health, NPA Weekly, May 2014.